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Today there is an urgent need for new antibiotics and novel cytotoxic compounds against cancer cells to
develop efficient alternative treatment to chemotherapy. We have searched for highly active Streptomyces
strains in the driest desert in the world, the Atacama desert in northern Chile. We have identified several new
strains and found many novel antibiotics, anticancer and antifungal agents from these strains.
A genome scale model of the metabolism of Streptomyces leeuwenhoekii C34 has been developed from its
genome sequence. The model, iVR1007, has 1726 reactions including 239 for transport, reactions for
secondary metabolite biosynthesis, 1463 metabolites and 1007 genes (1, 2). The validated model is presently
being used to increase and optimize the synthesis of Chaxamycins and Chaxalactins and the halogenase
cluster by recognizing overexpression targets and useful knock-out sites. Our latest overexpression results will
be presented.
In parallel, we have isolated new Streptomyces strains from Lupin rhizosphere soil from the Atacama desert.
Several strains were selected for their antifungal activity against Botrytis cinerea and Fusarium oxysporum, of
great agroindustrial importance. Mass spectrometry studies revealed at least 5 new molecules and one strain
was shown to produce more that 20 new desferrioxamines iron chelating molecules which act as fungal
inhibitors by iron deprivation. Currently DNA sequencing for the identification of gene clusters and in vitro
studies of fruit models are under way.
One of our latest strains Streptomyces asenjonii produces a range of Asenjonamides (A-C) and also
Spicamycins (A-E) which are potent antioxidant molecules with a beneficial effect on cell ageing.
Our latest work, in addition to the microbes from the Atacama desert, includes the Atacama Trench, which is
8,000 mts. deep and has never before been explored for microbial activity. Presently we are carrying out
detailed metagenomic analysis of the sediment samples taken at different depths. Initial results include the
isolation of Streptomyces, Salinispora and fungal strains which show antimicrobial activity against B. subtilis.
Our recent results concerned with overproduction and also findings of these novel potentially important
secondary metabolites will be presented and discussed in this presentation.
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